Karthik Kuppusamy's Insider Trades & SAST Disclosures
Karthik Kuppusamy's most recent trade in Quest Diagnostics, Inc. was a trade of 27 Common Stock done at an average price of $164.4 . Disclosure was reported to the exchange on April 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Karthik Kuppusamy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics, Inc. | Kuppusamy Karthik | SVP, Clinical Solutions | 21 Apr 2025 | 27 | 10,612 (0%) | 0% | 164.4 | 4,439 | Common Stock | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Sale of securities on an exchange or to another person at price $ 170.00 per share. | 02 Apr 2025 | 2,555 | 10,575 (0%) | 0% | 170 | 434,350 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 173.74 per share. | 03 Mar 2025 | 4,434 | 14,998 (0%) | 0% | 173.7 | 770,363 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 1,879 | 13,119 (0%) | 0% | 173.7 | 326,457 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 992 | 10,564 (0%) | 0% | 173.7 | 172,350 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 171.75 per share. | 26 Feb 2025 | 233 | 11,546 (0%) | 0% | 171.8 | 40,018 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 169.71 per share. | 19 Feb 2025 | 287 | 11,779 (0%) | 0% | 169.7 | 48,707 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 8,702 | 8,702 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 2,269 | 12,066 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | 29 Jan 2025 | 12 | 9,780 (0%) | 0% | 158 | 1,896 | Common Stock | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Sale of securities on an exchange or to another person at price $ 156.92 per share. | 28 Oct 2024 | 1,775 | 9,734 (0%) | 0% | 156.9 | 278,525 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | 21 Oct 2024 | 21 | 11,509 (0%) | 0% | 149.4 | 3,137 | Common Stock | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Sale of securities on an exchange or to another person at price $ 153.26 per share. | 28 Aug 2024 | 1,990 | 11,459 (0%) | 0% | 153.3 | 304,990 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.46 per share. | 14 Aug 2024 | 74 | 13,449 (0%) | 0% | 149.5 | 11,060 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | 22 Jul 2024 | 31 | 13,511 (0%) | 0% | 147.0 | 4,556 | Common Stock | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 29 Apr 2024 | 1,760 | 13,435 (0%) | 0% | 140 | 246,400 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 126.24 per share. | 22 Apr 2024 | 45 | 15,195 (0%) | 0% | 126.2 | 5,681 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 205 | 15,192 (0%) | 0% | 126.4 | 25,904 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.35 per share. | 28 Feb 2024 | 68 | 15,124 (0%) | 0% | 126.4 | 8,592 | Common Stock |
| Quest Diagnostics, Inc. | Kuppusamy Karthik | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 125.02 per share. | 23 Feb 2024 | 2,039 | 16,016 (0%) | 0% | 125.0 | 254,916 | Common Stock |
| Quest Diagnostics, Inc. | Kuppusamy Karthik | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 23 Feb 2024 | 619 | 15,397 (0%) | 0% | 125.0 | 77,387 | Common Stock |
| Quest Diagnostics, Inc. | Kuppusamy Karthik | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 21 Feb 2024 | 102 | 13,977 (0%) | 0% | 125.0 | 12,752 | Common Stock |
| Quest Diagnostics, Inc. | Kuppusamy Karthik | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 11,007 | 11,007 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Kuppusamy Karthik | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,641 | 14,079 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Kuppusamy Karthik | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 129.31 per share. | 31 Jan 2024 | 29 | 11,438 (0%) | 0% | 129.3 | 3,750 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 122.87 per share. | 23 Oct 2023 | 30 | 11,358 (0%) | 0% | 122.9 | 3,686 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.23 per share. | 15 Aug 2023 | 74 | 11,294 (0%) | 0% | 135.2 | 10,007 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 144.60 per share. | 25 Jul 2023 | 25 | 11,355 (0%) | 0% | 144.6 | 3,615 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | 24 Apr 2023 | 25 | 11,295 (0%) | 0% | 143.1 | 3,577 | Common Stock | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 147.86 per share. | 06 Mar 2023 | 1,985 | 11,824 (0%) | 0% | 147.9 | 293,502 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 06 Mar 2023 | 583 | 11,241 (0%) | 0% | 147.9 | 86,202 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.69 per share. | 01 Mar 2023 | 65 | 9,839 (0%) | 0% | 140.7 | 9,145 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 8,270 | 8,270 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,094 | 9,904 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 23 Feb 2023 | 195 | 7,810 (0%) | 0% | 147.9 | 28,833 | Common Stock |
| Quest Diagnostics, Inc. | Karthik Kuppusamy | SVP, Clinical Solutions | 01 Feb 2023 | 13 | 8,005 (0%) | 0% | 146.8 | 1,908 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges